全文获取类型
收费全文 | 1124篇 |
免费 | 81篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 39篇 |
妇产科学 | 56篇 |
基础医学 | 89篇 |
口腔科学 | 9篇 |
临床医学 | 126篇 |
内科学 | 290篇 |
皮肤病学 | 19篇 |
神经病学 | 102篇 |
特种医学 | 11篇 |
外科学 | 124篇 |
综合类 | 36篇 |
预防医学 | 209篇 |
眼科学 | 10篇 |
药学 | 35篇 |
中国医学 | 3篇 |
肿瘤学 | 49篇 |
出版年
2024年 | 3篇 |
2023年 | 14篇 |
2022年 | 2篇 |
2021年 | 18篇 |
2020年 | 10篇 |
2019年 | 5篇 |
2018年 | 20篇 |
2017年 | 16篇 |
2016年 | 23篇 |
2015年 | 19篇 |
2014年 | 19篇 |
2013年 | 27篇 |
2012年 | 100篇 |
2011年 | 88篇 |
2010年 | 31篇 |
2009年 | 23篇 |
2008年 | 90篇 |
2007年 | 98篇 |
2006年 | 72篇 |
2005年 | 83篇 |
2004年 | 107篇 |
2003年 | 96篇 |
2002年 | 65篇 |
2001年 | 49篇 |
2000年 | 13篇 |
1999年 | 14篇 |
1998年 | 14篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1995年 | 6篇 |
1994年 | 7篇 |
1993年 | 9篇 |
1992年 | 9篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 6篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 5篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1979年 | 2篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有1209条查询结果,搜索用时 15 毫秒
101.
Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression 下载免费PDF全文
102.
1998-2003年北京地区重症加强治疗病房急性呼吸窘迫综合征的临床流行病学调查 总被引:5,自引:1,他引:5
北京市科委重大项目MODS课题组 《中国危重病急救医学》2007,19(4):201-204
目的调查北京地区重症加强治疗病房(ICU)中急性呼吸窘迫综合征(ARDS)的发病情况、原发病、病死率及其影响因素。方法根据1994年欧美ARDS联席会议提出的ARDS诊断标准,回顾性调查1998年5月—2003年4月北京地区8家三级综合医院ICU中ARDS患者的病因、病死率及影响因素。结果383例ARDS患者占同期ICU收治危重患者的4.5%;脓毒症(21.7%)、肺炎(16.2%)、大手术(13.1%)、重症胰腺炎(12.8%)及多发性创伤(10.7%)是最常见的原发病;ARDS起病距原发病时间为(61.8±43.7)h。ARDS总病死率为52.0%,对病死率分别以年龄(≤39、40~64、≥65岁)、性别(男)进行调整,调整前后的病死率差异均有显著性(P均<0.05),对急性生理学与慢性健康状况评分系统Ⅱ评分(APACHEⅡ,≤12、13~19、≥20分)进行调整后的病死率5年间差异均无显著性。脓毒性休克(36.2%)与心功能衰竭(20.6%)是主要死亡原因,仅14.6%患者死于呼吸衰竭。结论ARDS是北京地区ICU中常见危重症,死亡率仍较高,且近年来并未下降。 相似文献
103.
Magis D Ambrosini A Bendtsen L Ertas M Kaube H Schoenen J;EUROHEAD Project 《Cephalalgia : an international journal of headache》2007,27(12):1323-1338
Neurophysiological testing has become a valuable tool for investigating brain excitability and nociceptive systems in headache disorders. Previous reviews have suggested that most neurophysiological tests have limited value for headache diagnosis, but a vast potential for exploring the pathophysiology of headaches, the central effects of certain pharmacological treatments and phenotype-genotype correlations. Many protocols, however, lack standardization. This meta-analytical review of neurophysiological methods in migraine was initiated by a task force within the EUROHEAD project (EU Strep LSHM-CT-2004–5044837-Workpackage 9). Most of the neurophysiological approaches that have been used in headache patients are reviewed, i.e. evoked potentials, nociception-specific blink reflex, single-fibre electromyography, neuroimaging methods (functional MRI, PET, and voxel-based morphometry) and the nitroglycerin attack-provoking test. For each of them, we summarize the results, analyse the methodological limitations and propose recommendations for improved methodology and standardization of research protocols. The first part is devoted to electrophysiological methods, the second to neuroimaging techniques and the NTG test. 相似文献
104.
OBJECTIVE: To assess both standard and novel diabetes quality measures in a national sample of U.S. academic medical centers. RESEARCH DESIGN AND METHODS: This retrospective cohort study was conducted from 10 January 2000 to 10 January 2002. It involved 30 U.S. academic medical centers, which contributed data from 44 clinics (27 primary care clinics and 17 diabetes/endocrinology clinics). For 1,765 eligible adult patients with type 1 or type 2 diabetes with at least two clinic visits in the 24 months before 10 January 2002, including one visit in the 6 months before 10 January 2002, we assessed measurement and control of HbA(1c), blood pressure, and cholesterol and corresponding medical regimen changes at the most recent clinic visit. RESULTS: In this ethnically and economically diverse cohort, annual testing rates were very high (97.4% for HbA(1c), 96.6% for blood pressure, and 87.6% for total cholesterol). Fewer patients were at HbA(1c) goal (34.0% <7.0%) or blood pressure goal (33.0% <130/80 mmHg) than lipid goals (65.1% total cholesterol <200 mg/dl, 46.1% with LDL cholesterol <100 mg/dl). Only 10.0% of the cohort met recommended goals for all three risk factors. At the most recent clinic visit, 40.4% of patients with HbA(1c) concentrations above goal underwent adjustment of their corresponding regimens. Among untreated patients, few with elevated blood pressure (10.1% with blood pressure >130/80 mmHg) or elevated LDL cholesterol (5.6% with LDL >100 mg/dl) were started on corresponding therapy. Patients with type 2 diabetes were no less likely to be intensified than patients with type 1 diabetes. CONCLUSIONS: High rates of risk factor testing do not necessarily translate to effective metabolic control. Low rates of medication adjustment among patients with levels above goal suggest a specific and novel target for quality improvement measurement. 相似文献
105.
106.
Leira R Castellanos M Alvarez-Sabín J Diez-Tejedor E Dávalos A Castillo J;Stroke Project Cerebrovascular Diseases Group of the Spanish Neurological Society 《Headache》2005,45(9):1236-1243
BACKGROUND AND PURPOSE: The mechanisms responsible for headache in patients with intracerebral hemorrhage (ICH) are not completely understood. The present study was undertaken to analyze the headache-associated factors, the possible related biochemical mechanisms, and the headache potential predictors of outcome in spontaneous ICH. METHODS: We prospectively studied 189 patients from a large cohort of 266 consecutive patients with supratentorial ICH admitted within the first 12 hours of symptoms onset. The presence of headache at stroke onset was evaluated in these patients. The volumes of the initial ICH, peripheral edema at 48 hours, and the residual cavity at 3 months were measured on CT scan. Glutamate, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha levels were measured in blood samples obtained on admission. The Canadian Stroke Scale (CSS) and the modified Rankin Scale were used to evaluate stroke severity and neurological outcome, respectively. RESULTS: Headache at onset of stroke was observed in 65 patients (34.4%). Patients who experienced headache had a significantly higher frequency of history of infection (P= .009) or inflammation (P= .045), as well as higher body temperature (P= .021), leukocyte count (P= .038), ESR (P= .011), and mass effect (P= .017) on admission. Plasma concentrations of IL-6 and TNF-alpha were significantly higher in patients with headache than in those without. Headache was an independent predictor of the residual cavity volume in patients with spontaneous ICH (odds ratio 6.49; 95% CI 2.51 to 16.78; P= .0001). CONCLUSIONS: Headache at ICH onset is associated with clinical and biochemical markers of inflammation and is an independent predictor of higher residual cavity volume after spontaneous ICH. 相似文献
107.
108.
Galloway GP Singleton EG Buscemi R Baggott MJ Dickerhoof RM Mendelson JE;Methamphetamine Treatment Project Corporate Authors 《The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions》2010,19(6):510-514
Craving for addictive drugs may predict relapse in abstinent addicts. To assess relationships between craving and use, we examined changes in craving for methamphetamine (MA) in a sample of 865 outpatients in a multisite 16-week MA-treatment study. Craving was assessed on a 0-100 scale, and MA use was assessed by self-report and confirmed by urinalysis. We hypothesized that the magnitude of craving would decline (decay) with increased time of abstinence, and that decay would be greater for more frequent MA users, and greater for intravenous (IV) users and smokers as compared to those who used MA intranasally. Craving declined significantly as the number of weeks of consecutive abstinence increased. Rate of decay was greater for IV users and smokers as compared to both intranasal users and oral users, but not for more frequent users of MA. Rate of decay was independent of age, gender, and race/ethnicity. The trajectory to 0 (no) craving was 1 week shorter for females than males because females had significantly lower pretreatment craving scores compared to males. This study confirms that the sooner MA-dependent people are able to quit using and the longer that they are able to stay abstinent, the more likely it is that their craving for MA will decrease over time. 相似文献
109.
Kevin M. Flanigan Diane M. Dunn Andrew von Niederhausern Payam Soltanzadeh Eduard Gappmaier Michael T. Howard Jacinda B. Sampson Jerry R. Mendell Cheryl Wall Wendy M. King Alan Pestronk Julaine M. Florence Anne M. Connolly Katherine D. Mathews Carrie M. Stephan Karla S. Laubenthal Brenda L. Wong Paula J. Morehart Amy Meyer Richard S. Finkel Carsten G. Bonnemann Livija Medne John W. Day Joline C. Dalton Marcia K. Margolis Veronica J. Hinton the United Dystrophinopathy Project Consortium Robert B. Weiss 《Human mutation》2009,30(12):1657-1666
Mutations in the DMD gene, encoding the dystrophin protein, are responsible for the dystrophinopathies Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), and X-linked Dilated Cardiomyopathy (XLDC). Mutation analysis has traditionally been challenging, due to the large gene size (79 exons over 2.2 Mb of genomic DNA). We report a very large aggregate data set comprised of DMD mutations detected in samples from patients enrolled in the United Dystrophinopathy Project, a multicenter research consortium, and in referral samples submitted for mutation analysis with a diagnosis of dystrophinopathy. We report 1,111 mutations in the DMD gene, including 891 mutations with associated phenotypes. These results encompass 506 point mutations (including 294 nonsense mutations) and significantly expand the number of mutations associated with the dystrophinopathies, highlighting the utility of modern diagnostic techniques. Our data supports the uniform hypermutability of CGA>TGA mutations, establishes the frequency of polymorphic muscle (Dp427m) protein isoforms and reveals unique genomic haplotypes associated with “private” mutations. We note that 60% of these patients would be predicted to benefit from skipping of a single DMD exon using antisense oligonucleotide therapy, and 62% would be predicted to benefit from an inclusive multiexonskipping approach directed toward exons 45 through 55. Hum Mutat 30:1657–1666, 2009. © 2009 Wiley-Liss, Inc. 相似文献
110.
Charron-Prochownik D Zgibor JC Peyrot M Peeples M McWilliams J Koshinsky J Noullet W Siminerio LM;AADE/UPMC Diabetes Education Outcomes Project 《The Diabetes educator》2007,33(5):833-838
PURPOSE: The purpose of this article is to present the results of the process evaluation and patient experience in completing the Diabetes Self-management Assessment Report Tool (D-SMART), an instrument within the AADE Outcome System to assist diabetes educators to assess, facilitate, and track behavior change in the provision of diabetes self-management education (DSME). METHODS: The D-SMART was integrated into computer and telephonic systems at 5 sites within the Pittsburgh Regional Initiative for Diabetes Education (PRIDE) network. Data were obtained from 290 patients with diabetes using the system at these programs via paper-and-pencil questionnaires following baseline D-SMART assessments and electronic system measurement of system performance. Process evaluation included time of completion, understanding content, usability of technology, and satisfaction with the system. Patients were 58% female and 85% Caucasian and had a mean age of 58 years. Fifty-six percent of patients had no more than a high school education, and 78% had Internet access at home. RESULTS: Most patients reported completing the D-SMART at home (78%), in 1 attempt (86%) via the Internet (55%), and in less than 30 minutes. Seventy-six percent believed the questions were easy to understand, and 80% did not need assistance. Age was negatively associated with ease of use. Moreover, 76% of patients believed the D-SMART helped them think about their diabetes, with 67% indicating that it gave the diabetes educator good information about themselves and their diabetes. Most (94%) were satisfied with the D-SMART. Level of satisfaction was independent of the system being used. CONCLUSIONS: The D-SMART was easily completed at home in 1 attempt, content was understandable, and patients were generally satisfied with the wording of questions and selection of answers. The D-SMART is easy to use and enhanced communication between the patient and clinician; however, elderly patients may need more assistance. Computer-based and telephonic D-SMARTs appear to be feasible and useful assessment methods for diabetes educators. 相似文献